These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8459887)

  • 41. Adverse event issue management: what have we learnt from pure red cell aplasia (PRCA)?
    Macdougall IC
    Nephrol Dial Transplant; 2005 Sep; 20 Suppl 8():viii18-21. PubMed ID: 16079325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolonged course of pure red cell aplasia after erythropoietin therapy.
    Nigg L; Schanz U; Ambühl PM; Fehr J; Bachli EB
    Eur J Haematol; 2004 Nov; 73(5):376-9. PubMed ID: 15458518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Azathioprine hypersensitivity in a renal transplant recipient.
    Vandepitte K; Vanrenterghem Y; Michielsen P
    Transpl Int; 1990 May; 3(1):47-8. PubMed ID: 2369481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pure red cell aplasia and acute hepatitis during pregnancy.
    Ohno Y; Itakura A; Sano M; Mizutani S
    Gynecol Obstet Invest; 2002; 53(2):112-3. PubMed ID: 11961385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study.
    Verhelst D; Rossert J; Casadevall N; Krüger A; Eckardt KU; Macdougall IC
    Lancet; 2004 May; 363(9423):1768-71. PubMed ID: 15172775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib.
    Poon LM; Koh LP
    Bone Marrow Transplant; 2012 Jun; 47(6):870-1. PubMed ID: 21874058
    [No Abstract]   [Full Text] [Related]  

  • 47. Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to re-introduction of cyclosporin.
    Hayden PJ; Gardiner N; Molloy K; Ryan J; Lawler M; McCann SR
    Bone Marrow Transplant; 2004 Feb; 33(4):459-61. PubMed ID: 14676777
    [No Abstract]   [Full Text] [Related]  

  • 48. Thymoma associated with pure red-cell aplasia: clinical features and prognosis.
    Murakawa T; Nakajima J; Sato H; Tanaka M; Takamoto S; Fukayama M
    Asian Cardiovasc Thorac Ann; 2002 Jun; 10(2):150-4. PubMed ID: 12079940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune-mediated pure red cell aplasia in renal transplant recipients.
    Zuber J; Beldjord K; Casadevall N; Thervet E; Legendre C; Varet B
    Haematologica; 2008 Nov; 93(11):1750-2. PubMed ID: 18790798
    [No Abstract]   [Full Text] [Related]  

  • 50. Antibodies to recombinant human erythropoietin causing pure red cell aplasia.
    Prabhakar SS; Muhlfelder T
    Clin Nephrol; 1997 May; 47(5):331-5. PubMed ID: 9181281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrent pure red cell aplasia in a hepatorenal transplant recipient with chronic parvovirus B19 infection.
    Rivas-Delgado A; Matutes E; Rozman M
    Br J Haematol; 2016 Feb; 172(4):495. PubMed ID: 26457576
    [No Abstract]   [Full Text] [Related]  

  • 52. Quiz page February 2011: acute kidney injury, graft pain, and subtherapeutic levels of tacrolimus.
    Lien YH; Bracamonte ER
    Am J Kidney Dis; 2011 Feb; 57(2):A25-9. PubMed ID: 21251536
    [No Abstract]   [Full Text] [Related]  

  • 53. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.9.2. Haematological complications. Leukopenia.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():49. PubMed ID: 12091648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Azathioprine-induced hepatic veno-occlusive disease in a renal transplant recipient: histological regression following azathioprine withdrawal.
    Kohli HS; Jain D; Sud K; Jha V; Gupta KL; Sakhuja V; Joshi K
    Nephrol Dial Transplant; 1996 Aug; 11(8):1671-2. PubMed ID: 8856241
    [No Abstract]   [Full Text] [Related]  

  • 55. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.
    Lagadinou ED; Marangos M; Liga M; Panos G; Tzouvara E; Dimitroulia E; Tiniakou M; Tsakris A; Zoumbos N; Spyridonidis A
    Transpl Infect Dis; 2010 Oct; 12(5):437-40. PubMed ID: 20561301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-Hodgkins lymphoma presenting as pure red cell aplasia.
    Salim S; Salim KA
    J Assoc Physicians India; 1992 Nov; 40(11):765-6. PubMed ID: 1307546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiotensin converting enzyme inhibitor induced anemia in a kidney transplant recipient.
    Kuriyama R; Kogure H; Itoh S; Kikuchi K; Ichikawa N; Nomura Y; Degawa H; Meigata K; Watanabe K; Beck Y; Tomikawa S; Nagao T; Uchida H
    Transplant Proc; 1996 Jun; 28(3):1635. PubMed ID: 8658817
    [No Abstract]   [Full Text] [Related]  

  • 58. Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights.
    Macdougall IC; Roger SD; de Francisco A; Goldsmith DJ; Schellekens H; Ebbers H; Jelkmann W; London G; Casadevall N; Hörl WH; Kemeny DM; Pollock C
    Kidney Int; 2012 Apr; 81(8):727-32. PubMed ID: 22336988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Homozygote deficiency of thiopurine methyltransferase. A contraindication to the use of azathioprine in kidney transplantation].
    Frappier J; Legendre C; Soria-Royer C; Barbanel C; Kreis H; Beaune P
    Presse Med; 1995 Sep; 24(27):1257-9. PubMed ID: 7501607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Four cases of thymoma associated with pure red cell aplasia].
    Mukaida T; Aoe M; Yamashita M; Date H; Ando A; Shimizu N
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Jan; 45(1):96-101. PubMed ID: 9028134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.